Follow your curiosity

What discovery has been shared with you?

Start with one fact. Explore it, go deeper, then follow whichever branch catches your imagination.

Choose subjects for a surprise

Exploring any topic

Begin your discovery

Your next discovery is one click away.

Choose one or more subjects above, or leave Any Topic selected and let curiosity decide.

Medicine

Histological Progression of Liver Fibrosis in Metabolic Dysfunction

Quick fact

Liver fibrosis in metabolic dysfunction is staged from F0 (no fibrosis) to F4 (cirrhosis), and the progression is not inevitable—it can regress if the metabolic insult is removed, especially in earlier stages.

Why this is interesting

Ever wondered why a 'fatty liver' can turn into scar tissue and eventually lead to liver failure? The answer lies in a step-by-step transformation of liver tissue that doctors can see under a microscope.

Read the full explanation

Understanding Histological Progression of Liver Fibrosis in Metabolic Dysfunction

Think of the liver as a busy factory. In metabolic dysfunction, fat accumulates inside liver cells (steatosis). This alone is often harmless. But when the fat triggers inflammation (steatohepatitis), the liver tries to repair itself by depositing collagen, like scar tissue on a wound. This scar tissue is fibrosis. Repeated cycles of damage and repair lead to progressive scarring, which distorts the liver's normal architecture. Histologists grade this from F0 (no fibrosis) to F4 (cirrhosis), where the liver is nodular and rigid. The biopsy is the gold standard to see this, but imaging can also estimate it.

A deeper explanation

The key driver of fibrosis is the activation of hepatic stellate cells. In a healthy liver, these cells store vitamin A and are quiescent. In response to injury—especially inflammation from steatohepatitis—they transform into myofibroblasts that secrete abundant extracellular matrix (collagen). This is the microscopic scar. Initially, fibrosis is pericellular (around hepatocytes), but it progresses to pericentral, then septal, and finally bridging fibrosis with nodules (cirrhosis). This architectural distortion impairs blood flow and liver function. Clinically, staging is crucial because F3–F4 increases the risk of hepatic decompensation and hepatocellular carcinoma. Histological assessment also distinguishes simple steatosis from steatohepatitis, which has a worse prognosis.

Keep FACTREE close

Internet access is required. Updates arrive when you reopen or reload the app. You may need to sign in again in the installed app.